Global Chronic Idiopathic Constipation Drugs Market Size, Status and Forecast 2022
This report studies the global Chronic Idiopathic Constipation Drugs market, analyzes and researches the Chronic Idiopathic Constipation Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like
This report focuses on the top players in global market, like
- Pfizer
- Glaxosmithkline
- Roche Holding AG
- Sanofi
- Bayer AG
- Merck
- Eli Lilly
- Allergens
- Chugai Pharmaceutical
- Ferring International Center S.A
- Synergy Pharmaceuticals
- Salix Pharmaceuticals Ltd
- Sucampo Pharmaceuticals Inc
- Ironwood Pharmaceuticals Inc
- Valeant Pharmaceuticals International
- Daiichi Sankyo
- Cosmo Pharmaceuticals SA
- Progenics Pharmaceuticals Inc
- Theravance Biopharma Inc
- United States
- EU
- Japan
- China
- India
- Southeast Asia
- Linaclotide
- Lubiprostone
- Other
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Chronic Idiopathic Constipation Drugs Market Size, Status and Forecast 2022
1 INDUSTRY OVERVIEW OF CHRONIC IDIOPATHIC CONSTIPATION DRUGS
1.1 Chronic Idiopathic Constipation Drugs Market Overview
1.1.1 Chronic Idiopathic Constipation Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Chronic Idiopathic Constipation Drugs Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Chronic Idiopathic Constipation Drugs Market by Type
1.3.1 Linaclotide
1.3.2 Lubiprostone
1.3.3 Other
1.4 Chronic Idiopathic Constipation Drugs Market by End Users/Application
1.4.1 Hospital Pharmacies
1.4.2 Retail Pharmacies
1.4.3 Online Pharmacies
2 GLOBAL CHRONIC IDIOPATHIC CONSTIPATION DRUGS COMPETITION ANALYSIS BY PLAYERS
2.1 Chronic Idiopathic Constipation Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 COMPANY (TOP PLAYERS) PROFILES
3.1 Pfizer
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Glaxosmithkline
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Roche Holding AG
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Sanofi
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Bayer AG
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Merck
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Eli Lilly
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Allergens
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Chugai Pharmaceutical
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Ferring International Center S.A
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Synergy Pharmaceuticals
3.12 Salix Pharmaceuticals Ltd
3.13 Sucampo Pharmaceuticals Inc
3.14 Ironwood Pharmaceuticals Inc
3.15 Valeant Pharmaceuticals International
3.16 Daiichi Sankyo
3.17 Cosmo Pharmaceuticals SA
3.18 Progenics Pharmaceuticals Inc
3.19 Theravance Biopharma Inc
4 GLOBAL CHRONIC IDIOPATHIC CONSTIPATION DRUGS MARKET SIZE BY TYPE AND APPLICATION (2012-2017)
4.1 Global Chronic Idiopathic Constipation Drugs Market Size by Type (2012-2017)
4.2 Global Chronic Idiopathic Constipation Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Chronic Idiopathic Constipation Drugs in Future
4.4 Top Consumer/End Users of Chronic Idiopathic Constipation Drugs
5 UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION DRUGS DEVELOPMENT STATUS AND OUTLOOK
5.1 United States Chronic Idiopathic Constipation Drugs Market Size (2012-2017)
5.2 United States Chronic Idiopathic Constipation Drugs Market Size and Market Share by Players (2016 and 2017)
6 EU CHRONIC IDIOPATHIC CONSTIPATION DRUGS DEVELOPMENT STATUS AND OUTLOOK
6.1 EU Chronic Idiopathic Constipation Drugs Market Size (2012-2017)
6.2 EU Chronic Idiopathic Constipation Drugs Market Size and Market Share by Players (2016 and 2017)
7 JAPAN CHRONIC IDIOPATHIC CONSTIPATION DRUGS DEVELOPMENT STATUS AND OUTLOOK
7.1 Japan Chronic Idiopathic Constipation Drugs Market Size (2012-2017)
7.2 Japan Chronic Idiopathic Constipation Drugs Market Size and Market Share by Players (2016 and 2017)
8 CHINA CHRONIC IDIOPATHIC CONSTIPATION DRUGS DEVELOPMENT STATUS AND OUTLOOK
8.1 China Chronic Idiopathic Constipation Drugs Market Size (2012-2017)
8.2 China Chronic Idiopathic Constipation Drugs Market Size and Market Share by Players (2016 and 2017)
9 INDIA CHRONIC IDIOPATHIC CONSTIPATION DRUGS DEVELOPMENT STATUS AND OUTLOOK
9.1 India Chronic Idiopathic Constipation Drugs Market Size (2012-2017)
9.2 India Chronic Idiopathic Constipation Drugs Market Size and Market Share by Players (2016 and 2017)
10 SOUTHEAST ASIA CHRONIC IDIOPATHIC CONSTIPATION DRUGS DEVELOPMENT STATUS AND OUTLOOK
10.1 Southeast Asia Chronic Idiopathic Constipation Drugs Market Size (2012-2017)
10.2 Southeast Asia Chronic Idiopathic Constipation Drugs Market Size and Market Share by Players (2016 and 2017)
11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)
11.1 Global Chronic Idiopathic Constipation Drugs Market Size (Value) by Regions (2017-2022)
11.1.1 United States Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2017-2022)
11.1.2 EU Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2017-2022)
11.1.3 Japan Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2017-2022)
11.1.4 China Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2017-2022)
11.1.5 India Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Chronic Idiopathic Constipation Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Chronic Idiopathic Constipation Drugs Market Size by Application (2017-2022)
12 CHRONIC IDIOPATHIC CONSTIPATION DRUGS MARKET DYNAMICS
12.1 Chronic Idiopathic Constipation Drugs Market Opportunities
12.2 Chronic Idiopathic Constipation Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Chronic Idiopathic Constipation Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Chronic Idiopathic Constipation Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 MARKET EFFECT FACTORS ANALYSIS
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 RESEARCH FINDING/CONCLUSION
15 APPENDIX
Methodology
Analyst Introduction
Data Source
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1 INDUSTRY OVERVIEW OF CHRONIC IDIOPATHIC CONSTIPATION DRUGS
1.1 Chronic Idiopathic Constipation Drugs Market Overview
1.1.1 Chronic Idiopathic Constipation Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Chronic Idiopathic Constipation Drugs Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Chronic Idiopathic Constipation Drugs Market by Type
1.3.1 Linaclotide
1.3.2 Lubiprostone
1.3.3 Other
1.4 Chronic Idiopathic Constipation Drugs Market by End Users/Application
1.4.1 Hospital Pharmacies
1.4.2 Retail Pharmacies
1.4.3 Online Pharmacies
2 GLOBAL CHRONIC IDIOPATHIC CONSTIPATION DRUGS COMPETITION ANALYSIS BY PLAYERS
2.1 Chronic Idiopathic Constipation Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 COMPANY (TOP PLAYERS) PROFILES
3.1 Pfizer
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Glaxosmithkline
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Roche Holding AG
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Sanofi
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Bayer AG
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Merck
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Eli Lilly
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Allergens
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Chugai Pharmaceutical
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Ferring International Center S.A
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Synergy Pharmaceuticals
3.12 Salix Pharmaceuticals Ltd
3.13 Sucampo Pharmaceuticals Inc
3.14 Ironwood Pharmaceuticals Inc
3.15 Valeant Pharmaceuticals International
3.16 Daiichi Sankyo
3.17 Cosmo Pharmaceuticals SA
3.18 Progenics Pharmaceuticals Inc
3.19 Theravance Biopharma Inc
4 GLOBAL CHRONIC IDIOPATHIC CONSTIPATION DRUGS MARKET SIZE BY TYPE AND APPLICATION (2012-2017)
4.1 Global Chronic Idiopathic Constipation Drugs Market Size by Type (2012-2017)
4.2 Global Chronic Idiopathic Constipation Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Chronic Idiopathic Constipation Drugs in Future
4.4 Top Consumer/End Users of Chronic Idiopathic Constipation Drugs
5 UNITED STATES CHRONIC IDIOPATHIC CONSTIPATION DRUGS DEVELOPMENT STATUS AND OUTLOOK
5.1 United States Chronic Idiopathic Constipation Drugs Market Size (2012-2017)
5.2 United States Chronic Idiopathic Constipation Drugs Market Size and Market Share by Players (2016 and 2017)
6 EU CHRONIC IDIOPATHIC CONSTIPATION DRUGS DEVELOPMENT STATUS AND OUTLOOK
6.1 EU Chronic Idiopathic Constipation Drugs Market Size (2012-2017)
6.2 EU Chronic Idiopathic Constipation Drugs Market Size and Market Share by Players (2016 and 2017)
7 JAPAN CHRONIC IDIOPATHIC CONSTIPATION DRUGS DEVELOPMENT STATUS AND OUTLOOK
7.1 Japan Chronic Idiopathic Constipation Drugs Market Size (2012-2017)
7.2 Japan Chronic Idiopathic Constipation Drugs Market Size and Market Share by Players (2016 and 2017)
8 CHINA CHRONIC IDIOPATHIC CONSTIPATION DRUGS DEVELOPMENT STATUS AND OUTLOOK
8.1 China Chronic Idiopathic Constipation Drugs Market Size (2012-2017)
8.2 China Chronic Idiopathic Constipation Drugs Market Size and Market Share by Players (2016 and 2017)
9 INDIA CHRONIC IDIOPATHIC CONSTIPATION DRUGS DEVELOPMENT STATUS AND OUTLOOK
9.1 India Chronic Idiopathic Constipation Drugs Market Size (2012-2017)
9.2 India Chronic Idiopathic Constipation Drugs Market Size and Market Share by Players (2016 and 2017)
10 SOUTHEAST ASIA CHRONIC IDIOPATHIC CONSTIPATION DRUGS DEVELOPMENT STATUS AND OUTLOOK
10.1 Southeast Asia Chronic Idiopathic Constipation Drugs Market Size (2012-2017)
10.2 Southeast Asia Chronic Idiopathic Constipation Drugs Market Size and Market Share by Players (2016 and 2017)
11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)
11.1 Global Chronic Idiopathic Constipation Drugs Market Size (Value) by Regions (2017-2022)
11.1.1 United States Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2017-2022)
11.1.2 EU Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2017-2022)
11.1.3 Japan Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2017-2022)
11.1.4 China Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2017-2022)
11.1.5 India Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Chronic Idiopathic Constipation Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Chronic Idiopathic Constipation Drugs Market Size by Application (2017-2022)
12 CHRONIC IDIOPATHIC CONSTIPATION DRUGS MARKET DYNAMICS
12.1 Chronic Idiopathic Constipation Drugs Market Opportunities
12.2 Chronic Idiopathic Constipation Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Chronic Idiopathic Constipation Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Chronic Idiopathic Constipation Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 MARKET EFFECT FACTORS ANALYSIS
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 RESEARCH FINDING/CONCLUSION
15 APPENDIX
Methodology
Analyst Introduction
Data Source
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Figure Chronic Idiopathic Constipation Drugs Product Scope
Figure Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) (2012-2017)
Table Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Chronic Idiopathic Constipation Drugs Market Share by Regions in 2016
Figure United States Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Chronic Idiopathic Constipation Drugs Market Share by Type in 2016
Figure Linaclotide Market Size (Million USD) and Growth Rate (2012-2017)
Figure Lubiprostone Market Size (Million USD) and Growth Rate (2012-2017)
Figure Other Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Chronic Idiopathic Constipation Drugs Market Share by Application in 2016
Table Key Downstream Customer in Hospital Pharmacies
Figure Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2012-2017)
Table Key Downstream Customer in Retail Pharmacies
Figure Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate in Retail Pharmacies (2012-2017)
Table Key Downstream Customer in Online Pharmacies
Figure Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate in Online Pharmacies (2012-2017)
Table Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2016
Figure Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2017
Table Pfizer Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Glaxosmithkline Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Glaxosmithkline (2012-2017)
Figure Glaxosmithkline Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Roche Holding AG Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Roche Holding AG (2012-2017)
Figure Roche Holding AG Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Sanofi (2012-2017)
Figure Sanofi Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Bayer AG Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Bayer AG (2012-2017)
Figure Bayer AG Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Merck Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Merck (2012-2017)
Figure Merck Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Eli Lilly Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Eli Lilly (2012-2017)
Figure Eli Lilly Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Allergens Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Allergens (2012-2017)
Figure Allergens Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Chugai Pharmaceutical Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Chugai Pharmaceutical (2012-2017)
Figure Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Ferring International Center S.A Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Ferring International Center S.A (2012-2017)
Figure Ferring International Center S.A Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Synergy Pharmaceuticals Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Synergy Pharmaceuticals (2012-2017)
Figure Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Salix Pharmaceuticals Ltd Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Salix Pharmaceuticals Ltd (2012-2017)
Figure Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Sucampo Pharmaceuticals Inc Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Sucampo Pharmaceuticals Inc (2012-2017)
Figure Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Ironwood Pharmaceuticals Inc Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Ironwood Pharmaceuticals Inc (2012-2017)
Figure Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Valeant Pharmaceuticals International Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Valeant Pharmaceuticals International (2012-2017)
Figure Valeant Pharmaceuticals International Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Daiichi Sankyo Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Daiichi Sankyo (2012-2017)
Figure Daiichi Sankyo Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Cosmo Pharmaceuticals SA Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Cosmo Pharmaceuticals SA (2012-2017)
Figure Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Progenics Pharmaceuticals Inc Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Progenics Pharmaceuticals Inc (2012-2017)
Figure Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Theravance Biopharma Inc Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Theravance Biopharma Inc (2012-2017)
Figure Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global Chronic Idiopathic Constipation Drugs Market Size Share by Type in 2012
Figure Global Chronic Idiopathic Constipation Drugs Market Size Share by Type in 2013
Figure Global Chronic Idiopathic Constipation Drugs Market Size Share by Type in 2014
Figure Global Chronic Idiopathic Constipation Drugs Market Size Share by Type in 2015
Figure Global Chronic Idiopathic Constipation Drugs Market Size Share by Type in 2016
Figure Global Chronic Idiopathic Constipation Drugs Market Size Share by Type in 2017
Table Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Application in 2012
Figure Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Application in 2013
Figure Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Application in 2014
Figure Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Application in 2015
Figure Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Application in 2016
Figure Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Chronic Idiopathic Constipation Drugs
Figure United States Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2016
Figure United States Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2017
Figure EU Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2016
Figure EU Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2017
Figure Japan Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2016
Figure Japan Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2017
Figure China Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Players (2012-2017)
Figure China Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2016
Figure China Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2017
Figure India Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Players (2012-2017)
Figure India Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2016
Figure India Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2017
Figure Southeast Asia Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2016
Figure Southeast Asia Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2017
Figure Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Regions (2017-2022)
Table Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global Chronic Idiopathic Constipation Drugs Market Size Share by Regions in 2017
Figure Global Chronic Idiopathic Constipation Drugs Market Size Share by Regions in 2022
Figure United States Chronic Idiopathic Constipation Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Chronic Idiopathic Constipation Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Chronic Idiopathic Constipation Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Chronic Idiopathic Constipation Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Chronic Idiopathic Constipation Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Chronic Idiopathic Constipation Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global Chronic Idiopathic Constipation Drugs Market Size Share by Type in 2017
Figure Global Chronic Idiopathic Constipation Drugs Market Size Share by Type in 2022
Table Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Application in 2017
Figure Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Application in 2022
Figure Chronic Idiopathic Constipation Drugs Product Scope
Figure Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) (2012-2017)
Table Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Chronic Idiopathic Constipation Drugs Market Share by Regions in 2016
Figure United States Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Chronic Idiopathic Constipation Drugs Market Share by Type in 2016
Figure Linaclotide Market Size (Million USD) and Growth Rate (2012-2017)
Figure Lubiprostone Market Size (Million USD) and Growth Rate (2012-2017)
Figure Other Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Chronic Idiopathic Constipation Drugs Market Share by Application in 2016
Table Key Downstream Customer in Hospital Pharmacies
Figure Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2012-2017)
Table Key Downstream Customer in Retail Pharmacies
Figure Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate in Retail Pharmacies (2012-2017)
Table Key Downstream Customer in Online Pharmacies
Figure Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate in Online Pharmacies (2012-2017)
Table Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2016
Figure Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2017
Table Pfizer Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Glaxosmithkline Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Glaxosmithkline (2012-2017)
Figure Glaxosmithkline Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Roche Holding AG Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Roche Holding AG (2012-2017)
Figure Roche Holding AG Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Sanofi (2012-2017)
Figure Sanofi Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Bayer AG Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Bayer AG (2012-2017)
Figure Bayer AG Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Merck Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Merck (2012-2017)
Figure Merck Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Eli Lilly Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Eli Lilly (2012-2017)
Figure Eli Lilly Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Allergens Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Allergens (2012-2017)
Figure Allergens Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Chugai Pharmaceutical Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Chugai Pharmaceutical (2012-2017)
Figure Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Ferring International Center S.A Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Ferring International Center S.A (2012-2017)
Figure Ferring International Center S.A Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Synergy Pharmaceuticals Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Synergy Pharmaceuticals (2012-2017)
Figure Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Salix Pharmaceuticals Ltd Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Salix Pharmaceuticals Ltd (2012-2017)
Figure Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Sucampo Pharmaceuticals Inc Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Sucampo Pharmaceuticals Inc (2012-2017)
Figure Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Ironwood Pharmaceuticals Inc Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Ironwood Pharmaceuticals Inc (2012-2017)
Figure Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Valeant Pharmaceuticals International Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Valeant Pharmaceuticals International (2012-2017)
Figure Valeant Pharmaceuticals International Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Daiichi Sankyo Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Daiichi Sankyo (2012-2017)
Figure Daiichi Sankyo Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Cosmo Pharmaceuticals SA Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Cosmo Pharmaceuticals SA (2012-2017)
Figure Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Progenics Pharmaceuticals Inc Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Progenics Pharmaceuticals Inc (2012-2017)
Figure Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Theravance Biopharma Inc Basic Information List
Table Chronic Idiopathic Constipation Drugs Business Revenue (Million USD) of Theravance Biopharma Inc (2012-2017)
Figure Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Business Revenue Market Share in 2016
Table Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global Chronic Idiopathic Constipation Drugs Market Size Share by Type in 2012
Figure Global Chronic Idiopathic Constipation Drugs Market Size Share by Type in 2013
Figure Global Chronic Idiopathic Constipation Drugs Market Size Share by Type in 2014
Figure Global Chronic Idiopathic Constipation Drugs Market Size Share by Type in 2015
Figure Global Chronic Idiopathic Constipation Drugs Market Size Share by Type in 2016
Figure Global Chronic Idiopathic Constipation Drugs Market Size Share by Type in 2017
Table Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Application in 2012
Figure Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Application in 2013
Figure Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Application in 2014
Figure Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Application in 2015
Figure Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Application in 2016
Figure Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Chronic Idiopathic Constipation Drugs
Figure United States Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2016
Figure United States Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2017
Figure EU Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2016
Figure EU Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2017
Figure Japan Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2016
Figure Japan Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2017
Figure China Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Players (2012-2017)
Figure China Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2016
Figure China Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2017
Figure India Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Players (2012-2017)
Figure India Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2016
Figure India Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2017
Figure Southeast Asia Chronic Idiopathic Constipation Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2016
Figure Southeast Asia Chronic Idiopathic Constipation Drugs Market Size Share by Players in 2017
Figure Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Regions (2017-2022)
Table Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global Chronic Idiopathic Constipation Drugs Market Size Share by Regions in 2017
Figure Global Chronic Idiopathic Constipation Drugs Market Size Share by Regions in 2022
Figure United States Chronic Idiopathic Constipation Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Chronic Idiopathic Constipation Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Chronic Idiopathic Constipation Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Chronic Idiopathic Constipation Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Chronic Idiopathic Constipation Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Chronic Idiopathic Constipation Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global Chronic Idiopathic Constipation Drugs Market Size Share by Type in 2017
Figure Global Chronic Idiopathic Constipation Drugs Market Size Share by Type in 2022
Table Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Application in 2017
Figure Global Chronic Idiopathic Constipation Drugs Market Size (Million USD) by Application in 2022
